BOARDS Sign In for Filters

Become a Member | Sign In

Board Stats

Madrigal Pharmaceuticals, Inc.

MDGL / Message Board

BOARD

GROUPS

Written By On Topic Only -- All Messages

Hide Replies

Keyword
Subject

Between			and
Rec'd By

Authored By
Minimum Recs

MSG #	SUBJECT	TYPE	AUTHOR	SENTIMENT	RECS	DATE POSTED
159	Timing	GN	Biotech_Jim		2	9/29/2023 7:19:29 AM

158	Madrigal Pharmaceuticals' NDA for resmetirom accepted by FDA	GN	jerrykrause		0	9/16/2023 11:51:28 AM

157	Madrigal Pharmaceuticals Appoints Bill Sibold as Chief Executive Officer	GN	Biotech_Jim		3	9/11/2023 7:35:15 AM

156	NDA submission completed	GN	ml_c2		2	7/17/2023 8:28:20 AM

155	EASL Stephen Harrison "Recaps the MAESTRO-NASH Program for Resmetirom"	GN	ml_c2		0	7/15/2023 9:58:58 AM

154	Parking the MAESTRO-NASH-OUTCOMES trial design (ongoing)	GN	Biotech_Jim		0	6/23/2023 8:49:53 AM

153	Re: MDGL P3 Maestro Nash data release	GN	lbl4321		1	6/22/2023 11:31:18 AM

151	Re: MDGL P3 Maestro Nash data release	GN	ml_c2		1	6/22/2023 9:14:28 AM

150	Re: MDGL P3 Maestro Nash data release	GN	lbl4321		0	6/22/2023 9:09:54 AM

149	MDGL P3 Maestro Nash data release	GN	ml_c2		3	6/22/2023 4:00:43 AM

Go to Msg #

Financial Market Data provided by